Redmile Group LLC Takes $5.54 Million Position in Prime Medicine

Redmile Group LLC has taken a $5.54 million position in Prime Medicine, Inc., purchasing 1,590,832 shares of the company's stock during the first quarter.

The fund's purchase accounts for 0.4% of its portfolio, making it Prime Medicine's 28th biggest holding. Redmile Group LLC owned 0.88% of Prime Medicine at the end of the most recent quarter.

Other large investors have also bought and sold shares of Prime Medicine during the first quarter, including Sei Investments Co., Dimensional Fund Advisors LP, Swiss National Bank, Wealthfront Advisers LLC, and Bank of New York Mellon Corp.